From everything J read it is all investigational but immunotherapy might offer targeted advancements. Caught earlier it might have better results but with HER2 disease we have more targets that we know can work.
All evidence points to my systemic disease being under control until I stopped herceptin in January. My central nervous system provided a safe haven for the disease. That's just 6 months of a chance of systemic disease progression. So far I'm looking at minor bone mets but there may be liver involvement. The liver is an amazing organ though and so starting back on targeted therapies might knock back a big fire. But if I need active tumor for immunotherapies options, one would suppose the sample could be prepared for additional options going forward.
Here are some links Im looking at:
https://www.clinicaltrials.gov/ct2/s...rm=TIL&rank=14
(A bit dire but has some good info)
http://www.curetoday.com/articles/is...-breast-cancer